Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 19 studies | 21% ± 5% | |
naive B cell | 15 studies | 23% ± 5% | |
regulatory T cell | 15 studies | 24% ± 5% | |
memory B cell | 13 studies | 21% ± 4% | |
CD4-positive, alpha-beta T cell | 8 studies | 21% ± 7% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 23% ± 4% | |
CD4-positive helper T cell | 3 studies | 23% ± 4% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 27% ± 1% | |
gamma-delta T cell | 3 studies | 30% ± 2% | |
T cell | 3 studies | 17% ± 1% | |
T follicular helper cell | 3 studies | 23% ± 1% | |
CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
CD4-positive, alpha-beta memory T cell | 3 studies | 22% ± 8% |
Insufficient scRNA-seq data for expression of P2RY10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 134.26 | 576 / 578 | 88% | 5.45 | 1022 / 1155 |
stomach | 67% | 32.31 | 241 / 359 | 72% | 3.80 | 207 / 286 |
breast | 56% | 27.16 | 257 / 459 | 82% | 6.04 | 916 / 1118 |
intestine | 61% | 151.70 | 588 / 966 | 68% | 2.76 | 357 / 527 |
thymus | 63% | 54.93 | 413 / 653 | 54% | 3.06 | 327 / 605 |
bladder | 52% | 30.29 | 11 / 21 | 57% | 2.21 | 287 / 504 |
kidney | 42% | 33.25 | 37 / 89 | 68% | 3.61 | 609 / 901 |
prostate | 56% | 26.91 | 136 / 245 | 49% | 1.48 | 248 / 502 |
uterus | 38% | 10.35 | 64 / 170 | 63% | 2.50 | 290 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.30 | 29 / 29 |
spleen | 100% | 636.69 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1273.08 | 911 / 929 | 0% | 0 | 0 / 0 |
esophagus | 33% | 12.97 | 480 / 1445 | 59% | 2.53 | 108 / 183 |
skin | 32% | 9.36 | 577 / 1809 | 59% | 4.68 | 277 / 472 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.67 | 39 / 45 |
liver | 48% | 15.22 | 108 / 226 | 30% | 1.10 | 123 / 406 |
adipose | 77% | 45.78 | 926 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 5% | 1.04 | 15 / 328 | 70% | 3.97 | 125 / 178 |
ovary | 18% | 4.87 | 33 / 180 | 39% | 0.91 | 166 / 430 |
blood vessel | 36% | 17.60 | 475 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 2.76 | 33 / 258 | 13% | 0.23 | 31 / 230 |
heart | 14% | 5.43 | 123 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 0.46 | 10 / 80 |
brain | 2% | 0.49 | 50 / 2642 | 4% | 0.12 | 26 / 705 |
muscle | 1% | 0.38 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | P2RY10 |
Protein name | Putative P2Y purinoceptor 10 (P2Y10) (P2Y-like receptor) |
Synonyms | |
Description | FUNCTION: Putative receptor for purines coupled to G-proteins. |
Accessions | ENST00000171757.3 ENST00000544091.1 O00398 |